The Relationship Between Fat Cell Dysfunction and Obesity-Related Complications
Overview
Abnormal adiposity leading to adverse health outcomes
This Class for
- Physician
- Resident / Fellow
What I will learn?
Demonstrate how adiposity dysfunction is a key driver of a wide variety of obesity-related complications.
Disclaimer
This content is approved by Eli Lilly and Company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly's prior permission
(This information/content is intended to Health Care Providers only)
For adverse events and safety reporting: email: saudi_pharmacovigilance@lilly.com
24 /7 mobile : +966 567 868 843 working hours: +966 11 461 7800 , Ext: 1
For Lilly product information: email: SAUDI_MEDINFOQUERIES@lilly.com
For further information, please contact:
Eli Lilly and Company, Scientific Office P.O. Box 92120 Riyadh 11653, Kingdom of Saudi Arabia. Tel: +966 11 461 7800 Fax: +966 111 217 9900 email: Saudi_Pharmacovigilance@lilly.com
PP-LD-SA-0464
Related Classes
- Advise on Glycemic and Weight Goals
- Assess Patient Readiness for Diabetes Care
- Targeting multiple pathways
- Post-GLP Podcast: needs of patients on GLP-1 RA with basal insulin
- Second generation basal insulin in advancing T2D therapy
- Soliqua and Unmet Needs Webinar Summary - William Polonsky and Kathrine
- Timely insulin initiation to limit disease progression
- SURMOUNT-5 Clinical Update–Now Published